Project VIBE: Virtual Intervention for Binge Eating in Adolescents
Launched by UNIVERSITY OF PITTSBURGH · Feb 4, 2025
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
The Project VIBE trial is testing a new mobile app designed to help teenagers who struggle with binge eating and have elevated weight. This innovative program aims to teach young people better ways to manage their eating habits over a 16-week period. Participants will use the app to track their eating behaviors and will provide feedback on how easy the app is to use and how well it helps them.
To be eligible for this study, teens must be between the ages of 12 and 18, have a body mass index (BMI) in the top 25% for their age and sex, and have experienced recent episodes of losing control over their eating or overeating. Participants will need a smartphone and internet access to participate. It's important to note that certain conditions, like being pregnant or having other serious eating disorders, would disqualify someone from joining. Overall, this trial offers a chance for teens to gain support in managing their eating behaviors with the help of modern technology.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • BMI≥75th percentile for their age and sex
- • Report recent loss of control eating and/or overeating (≥3 episodes of either type of eating behavior in the past 3 months)
- • Have an email address, Smartphone, and regular access to the internet
- • Be willing and able to measure their height and weight prior to study enrollment
- Exclusion Criteria:
- • Report more than 2 instances of compensatory behavior (e.g. diuretics, laxatives, vomiting, driven exercise) in the past 3 months
- • Not fluent in English at a third-grade reading level or higher
- • Currently taking medications known to affect weight or appetite or concurrently involved in treatment for eating or weight disorders
- • Meet criteria for a medical or psychiatric condition (e.g., diabetes, bulimia nervosa) known to significantly affect eating or weight, aside from binge eating disorder
- • Developmental or cognitive delay precluding participation in the intervention
- • Currently pregnant or lactating
About University Of Pittsburgh
The University of Pittsburgh is a leading research institution known for its commitment to advancing medical science and improving patient care through innovative clinical trials. With a robust infrastructure for research and a multidisciplinary approach, the university fosters collaboration among experts in various fields, facilitating the development of novel therapies and interventions. Its clinical trial programs emphasize ethical standards, patient safety, and the integration of cutting-edge technology, making the University of Pittsburgh a pivotal contributor to the landscape of clinical research and a trusted partner in the pursuit of health advancements.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Pittsburgh, Pennsylvania, United States
Chicago, Illinois, United States
Patients applied
Trial Officials
Andrea B Goldschmidt, Ph.D.
Principal Investigator
University of Pittsburgh
Andrea K Graham, Ph.D.
Principal Investigator
Northwestern University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported